VONTOBEL N/ CH0012335540 /
2024-06-13 5:30:22 PM | Chg. -0.40 | Volume | Bid8:15:13 AM | Ask8:15:13 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
52.90CHF | -0.75% | 33,382 Turnover: 1.77 mill. |
-Bid Size: 25 | -Ask Size: 125 | 3.01 bill.CHF | 5.67% | 13.70 |
GlobeNewswire
9:01 AM
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
9:00 AM
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
9:00 AM
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
9:00 AM
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
8:00 AM
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
7:00 AM
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...